Source link : https://newshealth.biz/health-news/novel-mimetic-bispecific-antibody-superior-to-standard-care-in-hemophilia-a/
Bleeding prophylaxis with an investigational factor VIIIa-mimetic bispecific antibody was superior to current standard of care in patients with hemophilia A with or without inhibitors. Depending on the regimen of the study drug, 64% to 95% of patients remained free of treated bleeding events during 26 weeks. Factor VIIIa mimetics that require less frequent subcutaneous […]
The post Novel Mimetic Bispecific Antibody Superior to Standard Care in Hemophilia A first appeared on News Health.
—-
Author : News Health
Publish date : 2026-04-29 21:42:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8